An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Vertex Pharmaceuticals (NASDAQ: VRTX) is set to report its Q1 2022 financial results on May 5, 2022, after market close. A conference call for investors will follow at 4:30 p.m. ET. Interested parties can participate by calling (877) 270-2148 for U.S. inquiries or +1 (412) 902-6510 internationally. Vertex focuses on developing transformative medicines for serious diseases, particularly cystic fibrosis, and has a promising pipeline for other serious conditions. The company's ongoing innovation and multiple approved treatments showcase its leadership in the biotechnology field.
Positive
Vertex has multiple approved medicines treating cystic fibrosis, indicating strong market presence and revenue potential.
The company has an extensive pipeline with investigational therapies targeting serious diseases, which may drive future growth.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2022 financial results on Thursday, May 5, 2022 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (877) 270-2148 (U.S.) or +1 (412) 902-6510 (International) and reference the “Vertex Pharmaceuticals First Quarter 2022 Earnings Call”.
The conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at www.vrtx.com in the "Investors" section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.
Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston'sInnovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 12 consecutive years on Science magazine's Top Employers list and one of the 2021 Seramount (formerly Working Mother Media) 100 Best Companies. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.
When will Vertex Pharmaceuticals report its Q1 2022 earnings?
Vertex Pharmaceuticals will report its Q1 2022 financial results on May 5, 2022.
What time will the Vertex Pharmaceuticals earnings call be held?
The earnings call will be held at 4:30 p.m. ET on May 5, 2022.
How can I listen to the Vertex Pharmaceuticals earnings call?
To listen to the earnings call, dial (877) 270-2148 for U.S. calls or +1 (412) 902-6510 for international calls.
What is Vertex Pharmaceuticals' stock symbol?
Vertex Pharmaceuticals is traded under the stock symbol VRTX.
What diseases does Vertex Pharmaceuticals focus on?
Vertex Pharmaceuticals focuses on cystic fibrosis and has investigational therapies for other serious diseases like sickle cell disease and type 1 diabetes.
